BeStock  
Markets › Compare › CGON vs RMBS

CGON vs RMBS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CGON · CG Oncology$79.47 ▼ 2.97%
RMBS · Rambus$66.35 ▼ 12.92%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6499133168202Nov 24, '25May 26, '26Nov 20, '26
  • CGON +82.4%
  • RMBS -28.5%

Head to head

MetricCGONRMBS
Price$79.47$66.35
Change today▼ 2.97%▼ 12.92%
Market cap$7.10B$7.11B
Return, 3 months+1.6%-23.8%
Return, year to date+91.4%-27.8%
Return, 1 year+87.3%-24.7%
P/E (TTM)–27.4
P/B7.25.0
P/E percentile vs own 5y47th58th
Dividend yield––
Revenue growth (YoY, latest qtr)-3.7%+22.3%
Net profit growth (YoY)-29.9%+54.1%
Gross margin-104.8%79.1%
Operating margin-4,293.5%36.7%
Net margin-3,851.1%33.4%
Return on equity-28.3%19.6%
Analyst target vs. price+13.3%+87.4%
Analyst buy share100%50%
RSI (14)6032
30-day volatility75.2%92.5%
Max drawdown, 1 year-27.4%-61.1%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • RMBS is the largest of the group by market value.
  • CGON has returned the most over the past year.
  • RMBS is growing revenue fastest.
  • RMBS keeps the most profit per dollar of sales.
  • CGON has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top